Search Results - "SAMESHIMA, HISAYO"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process by Hosokawa, Kazuya, Ohnishi, Tomoko, Fukasawa, Masashi, Kondo, Taro, Sameshima, Hisayo, Koide, Takehiko, Tanaka, Kenichi A., Maruyama, Ikuro

    Published in Microvascular research (01-03-2012)
    “…As the pathogenesis of arterial thrombosis often includes platelet thrombus formation (PTF), antiplatelet agents are commonly used for the prevention of…”
    Get full text
    Journal Article
  2. 2

    Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model by Hosokawa, Kazuya, Ohnishi, Tomoko, Sameshima, Hisayo, Miura, Naoki, Koide, Takehiko, Maruyama, Ikuro, Tanaka, Kenichi A

    Published in PloS one (31-01-2014)
    “…Dabigatran and rivaroxaban are novel oral anticoagulants that specifically inhibit thrombin and factor Xa, respectively. The aim of this study is to elucidate…”
    Get full text
    Journal Article
  3. 3

    Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions by Hosokawa, Kazuya, Ohnishi, Tomoko, Miura, Naoki, Sameshima, Hisayo, Koide, Takehiko, Tanaka, Kenichi A, Maruyama, Ikuro

    Published in Thrombosis research (01-01-2014)
    “…Abstract Introduction Thrombin-mediated activation of human platelets involves the G-protein-coupled protease-activated receptors PAR1 and PAR4. Inhibition of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Nucleophosmin may act as an alarmin: implications for severe sepsis by Nawa, Yuko, Kawahara, Ko‐ichi, Tancharoen, Salunya, Meng, Xiaojie, Sameshima, Hisayo, Ito, Takashi, Masuda, Yoshiki, Imaizumi, Hitoshi, Hashiguchi, Teruto, Maruyama, Ikuro

    Published in Journal of leukocyte biology (01-09-2009)
    “…Nucleophosmin exerts potent biological activities that contribute to systemic inflammation. NPM is a major nucleolar multifunctional protein involved in…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Attenuation of LPS-induced iNOS expression by 1,5-anhydro- d-fructose by Meng, Xiaojie, Kawahara, Ko-ichi, Matsushita, Kenji, Nawa, Yuko, Shrestha, Binita, Kikuchi, Kiyoshi, Sameshima, Hisayo, Hashiguchi, Teruto, Maruyama, Ikuro

    “…1,5-anhydro- d-fructose (1,5-AF), a monosaccharide formed from starch and glycogen, exhibits antioxidant and antibacterial activity, and inhibits cytokine…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions by Hosokawa, Kazuya, Ohnishi, Tomoko, Sameshima, Hisayo, Miura, Naoki, Ito, Takashi, Koide, Takehiko, Maruyama, Ikuro

    Published in Thrombosis and haemostasis (01-01-2013)
    “…High residual platelet aggregability and circulating platelet-monocyte aggregates in patients administered aspirin and clopidogrel are associated with…”
    Get more information
    Journal Article
  11. 11

    Combined Dabigatran and Antiplatelet Agents Assessed by the Novel Microchip-Based Flow Chamber System by Tanaka, Kenichi, Hosokawa, Kazuya, Ohnishi, Tomoko, Sameshima, Hisayo, Koide, Takehiko, Maruyama, Ikuro

    Published in Blood (16-11-2012)
    “…Abstract 1167 Evaluation of the overall antithrombotic activity of dabigatran in combination with antiplatelet agents is difficult because plasma-based…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    1,5-Anhydro- d-fructose attenuates lipopolysaccharide-induced cytokine release via suppression of NF-κB p65 phosphorylation by Meng, Xiaojie, Kawahara, Ko-ichi, Nawa, Yuko, Miura, Naoki, Shrestha, Binita, Tancharoen, Salunya, Sameshima, Hisayo, Hashiguchi, Teruto, Maruyama, Ikuro

    “…Lipopolysaccharide (LPS) stimulates macrophages by activating NF-κB, which contributes to the release of tumor necrosis factor (TNF)-α and interleukin (IL)-6…”
    Get full text
    Journal Article
  15. 15

    1,5-Anhydro-D-fructose attenuates lipopolysaccharide-induced cytokine release via suppression of NF-{kappa}B p65 phosphorylation by Meng Xiaojie, Kawahara, Ko-ichi, Nawa, Yuko, Miura, Naoki, Shrestha, Binita, Tancharoen, Salunya, Sameshima, Hisayo, Hashiguchi, Teruto, Maruyama, Ikuro

    “…Lipopolysaccharide (LPS) stimulates macrophages by activating NF-{kappa}B, which contributes to the release of tumor necrosis factor (TNF)-{alpha} and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    New methodological approaches for assessing thrombus formation in cardiovascular disease by Hosokawa, Kazuya, Ohnishi-Wada, Tomoko, Nagasato, Tomoka, Sameshima-Kaneko, Hisayo, Oyamada, Chiaki, Dahlen, Jeffrey

    Published in Kardiologia polska (25-08-2020)
    “…Antiplatelet therapy is the mainstay preventive strategy for cardiovascular diseases, and dual antiplatelet therapy comprising aspirin and a P2Y12 inhibitor is…”
    Get full text
    Journal Article
  18. 18
  19. 19

    1,5-Anhydro-D-fructose attenuates lipopolysaccharide-induced cytokine release via suppression of NF-kappaB p65 phosphorylation by Meng, Xiaojie, Kawahara, Ko-ichi, Nawa, Yuko, Miura, Naoki, Shrestha, Binita, Tancharoen, Salunya, Sameshima, Hisayo, Hashiguchi, Teruto, Maruyama, Ikuro

    “…Lipopolysaccharide (LPS) stimulates macrophages by activating NF-kappaB, which contributes to the release of tumor necrosis factor (TNF)-alpha and interleukin…”
    Get full text
    Journal Article